Zacks: Brokerages Expect Intuitive Surgical (ISRG) Will Post Earnings of $1.99 Per Share

Wall Street brokerages expect Intuitive Surgical (NASDAQ:ISRG) to post earnings per share (EPS) of $1.99 for the current fiscal quarter, according to Zacks. Five analysts have made estimates for Intuitive Surgical’s earnings, with the highest EPS estimate coming in at $2.18 and the lowest estimate coming in at $1.64. Intuitive Surgical posted earnings per share of $1.70 during the same quarter last year, which would indicate a positive year-over-year growth rate of 17.1%. The company is scheduled to announce its next quarterly earnings results after the market closes on Tuesday, April 17th.

According to Zacks, analysts expect that Intuitive Surgical will report full-year earnings of $9.61 per share for the current financial year, with EPS estimates ranging from $9.37 to $10.00. For the next financial year, analysts expect that the company will post earnings of $10.82 per share, with EPS estimates ranging from $9.53 to $11.98. Zacks’ EPS calculations are a mean average based on a survey of analysts that follow Intuitive Surgical.

How to Become a New Pot Stock Millionaire

Intuitive Surgical (NASDAQ:ISRG) last issued its earnings results on Thursday, January 25th. The medical equipment provider reported $2.54 EPS for the quarter, beating the Zacks’ consensus estimate of $2.27 by $0.27. The firm had revenue of $892.40 million for the quarter, compared to analyst estimates of $866.54 million. Intuitive Surgical had a return on equity of 19.93% and a net margin of 21.09%. Intuitive Surgical’s revenue for the quarter was up 17.9% on a year-over-year basis. During the same quarter in the prior year, the firm earned $2.03 earnings per share.

A number of equities research analysts recently commented on ISRG shares. ValuEngine lowered Intuitive Surgical from a “hold” rating to a “sell” rating in a research report on Friday, December 29th. Zacks Investment Research upgraded Intuitive Surgical from a “hold” rating to a “buy” rating and set a $488.00 target price on the stock in a research report on Tuesday, March 20th. Morgan Stanley upped their target price on Intuitive Surgical from $450.00 to $500.00 and gave the company an “overweight” rating in a research report on Friday, January 26th. Citigroup dropped their target price on Intuitive Surgical to $507.00 and set a “buy” rating on the stock in a research report on Tuesday, February 6th. Finally, Vetr upgraded Intuitive Surgical from a “hold” rating to a “buy” rating and set a $434.75 target price on the stock in a research report on Monday, January 8th. One research analyst has rated the stock with a sell rating, six have given a hold rating, thirteen have issued a buy rating and one has issued a strong buy rating to the stock. The company has a consensus rating of “Buy” and a consensus target price of $413.77.

In other Intuitive Surgical news, CEO Gary S. Guthart sold 28,525 shares of the company’s stock in a transaction that occurred on Monday, February 5th. The stock was sold at an average price of $414.50, for a total value of $11,823,612.50. Following the sale, the chief executive officer now owns 311,469 shares in the company, valued at approximately $129,103,900.50. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, CFO Marshall Mohr sold 7,500 shares of the company’s stock in a transaction that occurred on Monday, February 5th. The stock was sold at an average price of $414.19, for a total value of $3,106,425.00. Following the completion of the sale, the chief financial officer now owns 13,816 shares in the company, valued at approximately $5,722,449.04. The disclosure for this sale can be found here. In the last 90 days, insiders sold 102,770 shares of company stock worth $43,410,836. Insiders own 2.20% of the company’s stock.

Large investors have recently made changes to their positions in the company. Point72 Asset Management L.P. purchased a new position in shares of Intuitive Surgical during the 3rd quarter valued at approximately $24,264,000. Chevy Chase Trust Holdings Inc. lifted its position in shares of Intuitive Surgical by 206.2% during the 4th quarter. Chevy Chase Trust Holdings Inc. now owns 179,792 shares of the medical equipment provider’s stock valued at $65,613,000 after buying an additional 121,082 shares in the last quarter. Atria Investments LLC lifted its position in shares of Intuitive Surgical by 189.4% during the 4th quarter. Atria Investments LLC now owns 1,777 shares of the medical equipment provider’s stock valued at $648,000 after buying an additional 1,163 shares in the last quarter. Shaker Investments LLC OH lifted its position in shares of Intuitive Surgical by 200.0% during the 4th quarter. Shaker Investments LLC OH now owns 2,100 shares of the medical equipment provider’s stock valued at $766,000 after buying an additional 1,400 shares in the last quarter. Finally, Gulf International Bank UK Ltd lifted its position in shares of Intuitive Surgical by 200.0% during the 4th quarter. Gulf International Bank UK Ltd now owns 35,841 shares of the medical equipment provider’s stock valued at $13,079,000 after buying an additional 23,894 shares in the last quarter. Hedge funds and other institutional investors own 87.89% of the company’s stock.

NASDAQ ISRG traded down $0.42 during trading hours on Friday, reaching $414.63. The stock had a trading volume of 470,072 shares, compared to its average volume of 753,555. The firm has a market cap of $46,926.42, a P/E ratio of 57.67, a P/E/G ratio of 4.94 and a beta of 0.57. Intuitive Surgical has a 52-week low of $251.13 and a 52-week high of $452.00.

ILLEGAL ACTIVITY WARNING: This piece of content was originally reported by Chaffey Breeze and is the property of of Chaffey Breeze. If you are viewing this piece of content on another website, it was stolen and republished in violation of international trademark & copyright legislation. The legal version of this piece of content can be viewed at https://www.chaffeybreeze.com/2018/04/15/zacks-brokerages-expect-intuitive-surgical-isrg-will-post-earnings-of-1-99-per-share.html.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. The company's da Vinci surgical System translates a surgeon's natural hand movements, which are performed on instrument controls at a console into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.

Get a free copy of the Zacks research report on Intuitive Surgical (ISRG)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply